Lars Rebien Sørensen - Ferring Global

Lars Rebien Sørensen

Lars Rebien Sørensen

Vice-Chairman

Lars became Chairman of Ferring’s Board of Directors in July 2021 and was appointed Vice-Chairman in July 2023 when Jean-Frédéric Paulsen assumed the role of Chairman. He is Chair of the Board of Novo Nordisk and the Novo Nordisk Foundation, and a member of the Board of Jungbunzlauer Suisse AG. Lars has more than 35 years’ management experience in the pharmaceutical industry and drove financial and sustainability performance as President and CEO of Novo Nordisk A/S from 2000 to 2016, and Chair of Novo Holdings A/S from 2018 to 2025. He serves as an Adjunct Professor at the University of Copenhagen’s School of Life Sciences, and at the Center for Corporate Governance at Copenhagen Business School in Denmark. He holds a Master’s degree in forestry from the Copenhagen Royal Veterinary and Agricultural University and a B.Sc. in international economics from Copenhagen Business School.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK